Eli Lilly

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Eli Lilly and other ETFs, options, and stocks.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.

CEO

David A. Ricks

CEODavid A. Ricks

Employees

43,000

Employees43,000

Headquarters

Indianapolis, Indiana

HeadquartersIndianapolis, Indiana

Founded

1876

Founded1876

Employees

43,000

Employees43,000

LLY Key Statistics

Market cap

709.89B

Market cap709.89B

Price-Earnings ratio

82.03

Price-Earnings ratio82.03

Dividend yield

0.67%

Dividend yield0.67%

Average volume

4.94M

Average volume4.94M

High today

$761.28

High today$761.28

Low today

$745.08

Low today$745.08

Open price

$755.00

Open price$755.00

Volume

4.02M

Volume4.02M

52 Week high

$972.53

52 Week high$972.53

52 Week low

$561.65

52 Week low$561.65

LLY News

Investor's Business Daily 16h

Is Eli Lilly Stock A Sell After Kennedy-Tied Woes Rankled Shares?

Eli Lilly stock has dropped since Trump announced his plan to appoint Kennedy to the HHS lead role. Is LLY stock a sell? View comments...

Seeking Alpha 1d

Hims & Hers closes up 10% as Lilly tirzepatide compounding dispute resolution delayed

Him & Hers Health (NYSE:HIMS) closed up ~10% Thursday after a federal court in Texas administratively closed a case in which a compounding drugs industry associ...

Benzinga 2d

Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs

Eli Lilly and Co. LLY has seen better days. The stock is up 26.04% for the last year but has struggled recently, falling 17.57% over the last month. Chart crea...

Analyst ratings

81%

of 31 ratings

Buy

80.6%

Hold

16.1%

Sell

3.2%

More LLY News

Benzinga 2d

Eli Lilly Board Member Trades $229K In Company Stock - Benzinga

...

Barron's 2d

Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop

Eli Lilly, Novo Nordisk, and Amgen all look cheap. All of them could experience a massive boost to profits in the years to come. View comments...

TipRanks 2d

Eli Lilly and China-based biotech Laekna team on obesity drug

Earlier on Wednesday, Laekna, “a global biotech company focused on novel drug development for metabolic and cancer diseases,” accoding to its release, announced...

Benzinga 3d

Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate

On Wednesday, Verge Genomics announced that Eli Lilly And Co LLY has opted to pursue the development of therapeutics against two validated drug targets for amyo...

Seeking Alpha 3d

Eli Lilly in pact with Chinese biotech for novel weight loss therapy

Chinese biotech Laekna Therapeutics on Wednesday announced a clinical collaboration with Eli Lilly (NYSE:LLY) to develop an obesity therapy that can avoid loss...

TipRanks 3d

Eli Lilly, Verge announce milestones in ALS collaboration

Verge Genomics announced that Eli Lilly (LLY) has opted to pursue the development of therapeutics against two validated drug targets for amyotrophic lateral scl...

TipRanks 3d

Laekna Partners with Eli Lilly on Obesity Drug Development

Laekna, Inc. (HK:2105) has released an update. Don't Miss out on Research Tools: Discover the latest stocks recommended by top Wall Street analysts, all in one...